Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 8–8 | Cite as

DPP-4 inhibitors increase risk of bullous pemphigoid in diabetics

Clinical study
  • 32 Downloads

Reference

  1. Lee SG, et al. Association of Dipeptidyl Peptidase 4 Inhibitor Use With Risk of Bullous Pemphigoid in Patients With Diabetes. JAMA Dermatology : 9 Jan 2019. Available from: URL: http://doi.org/10.1001/jamadermatol.2018.4556

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations